Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Development of an immune or autoimmune response involves T-cell activation in lymphoid organs and subsequent migration to peripheral tissues. Here we show that T-cell-specific ablation of the kinase TBK1 promotes T-cell activation but causes retention of effector T cells in the draining lymph node in a neuroinflammatory autoimmunity model, experimental autoimmune encephalomyelitis (EAE). At older ages, the T-cell-conditional TBK1-knockout mice also spontaneously accumulate T cells with activated phenotype. TBK1 controls the activation of AKT and its downstream kinase mTORC1 by a mechanism involving TBK1-stimulated AKT ubiquitination and degradation. The deregulated AKT-mTORC1 signalling in turn contributes to enhanced T-cell activation and impaired effector T-cell egress from draining lymph nodes. Treatment of mice with a small-molecule inhibitor of TBK1 inhibits EAE induction. These results suggest a role for TBK1 in regulating T-cell migration and establish TBK1 as a regulator of the AKT-mTORC1 signalling axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated critical roles for TBK1 and/or IKK ε in regulation of activity of numerous immune cell types, including T cells 21 , B cells 22,23 , dendritic cells 24 , and macrophages 25,26 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“In keeping with this, Tbk1 deletion disrupts the migration of T-cells [216] that may exert anti-inflammatory effects in ALS models [192,217].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [216]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 1×
“The T-cell priming and differentiation are governed by signal transduction mediated by the TCR and a costimulatory molecule, CD28, as well as cytokine signals 6 .”
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 2×
“In vitro T-cell migration assays were performed using a 24-well plate Boyden chamber essentially as previously described 33 .”
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“The central nervous system (CNS) is an organ of a number of autoimmune and inflammatory disorders, including multiple sclerosis, a disease characterized by chronic inflammation, demyelination, and neuronal damage 2 .”
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206 · cited 1×
“5) 22–24 .”
Regulation and function of mTOR signalling in T cell fate decisions
Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030 · cited 1×
“It is generally believed that in MS and EAE, autoimmune T cells are primed by myelin-specific antigens and then migrate across the blood-brain barrier to enter the CNS, where they become reactivated and mediate inflammation and neuronal damage 4,5 .”
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice
Arbonés, M. L., Ord, D. C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, D. J., & Teddert, T. F. (1994) · Immunity · doi:10.1016/1074-7613(94)90076-0 · Cited by 831 · cited 1×
“2d), they did not have a defect in T-cell homing to the lymph nodes as shown for the CD62L-deficient mice 19,20 .”
The integration of T cell migration, differentiation and function
Masopust, D., & Schenkel, J. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3442 · Cited by 627 · cited 1×
“Newly activated T cells express low levels of the factors involved in T-cell migration, particularly the transcription factor KLF2 and its target gene product S1PR1, which is correlated with the lymphoid retention of the T cells 39 .”
Kruppel-like factor 2 regulates thymocyte and T-cell migration
Carlson, C. M., Endrizzi, B. T., Wu, J., Ding, X., Weinreich, M. A., Walsh, E. R., Wani, M. A., Lingrel, J. B., Hogquist, K. A., & Jameson, S. C. (2006) · Nature · doi:10.1038/nature04882 · Cited by 593 · cited 1×
“The role of KLF2 and S1PR1 in mediating T-cell migration has been directly demonstrated in a number of studies 37,40,41 .”
Hemmi, H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., & Akira, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040520 · Cited by 576
Kerdiles, Y. M., Beisner, D. R., Tinoco, R., Dejean, A. S., Castrillon, D. H., DePinho, R. A., & Hedrick, S. M. (2009) · Nature Immunology · doi:10.1038/ni.1689 · Cited by 541 · cited 2×
“Besides mTORC1, several other factors in the related pathways, including the transcription factors Foxo1 and KLF2, are required for maintaining T-cell homeostasis 37,38 .”
McWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T., & Maniatis, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237236100 · Cited by 540
Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells
Sprent, J., & Surh, C. D. (2011) · Nature Immunology · doi:10.1038/ni.2018 · Cited by 479
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israel, A., et al. (2002) · Nature · doi:10.1038/nature00820 · Cited by 470 · cited 1×
“Mice with loxP-flanked allele encoding IKK β (IKK2) or NEMO alleles were provided by Dr. Manolis Pasparakis (University of Cologne) 47 .”
T cells become licensed in the lung to enter the central nervous system
Odoardi, F., Sie, C., Streyl, K., Ulaganathan, V. K., Schläger, C., Lodygin, D., Heckelsmiller, K., Nietfeld, W., Ellwart, J., Klinkert, W. E. F., et al. (2012) · Nature · doi:10.1038/nature11337 · Cited by 442 · cited 4×
“5) 22–24 .”
InfluentialReilly, S. M., Chiang, S.-H., Decker, S. J., Chang, L., Uhm, M., Larsen, M. J., Rubin, J. R., Mowers, J., White, N. M., Hochberg, I., et al. (2013) · Nature Medicine · doi:10.1038/nm.3082 · Cited by 433
Pham, T. H. M., Okada, T., Matloubian, M., Lo, C. G., & Cyster, J. G. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.017 · Cited by 427 · cited 1×
“The role of KLF2 and S1PR1 in mediating T-cell migration has been directly demonstrated in a number of studies 37,40,41 .”
Perry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W.-C., & Cheng, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040528 · Cited by 399 · cited 2×
“TBK1, as well as its homologous kinase IKK ε , are known as mediators of type I interferon (IFN) induction in antiviral innate immunity 7–11 .”
Bonnard, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.18.4976 · Cited by 381 · cited 1×
“In particular, the study of the in vivo function of TBK1 has been hampered by the embryonic lethality of the conventional TBK1 knockout (KO) mice 15 .”
CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation
Gaide, O., Favier, B., Legler, D. F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., & Thome, M. (2002) · Nature Immunology · doi:10.1038/ni830 · Cited by 343
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Hara, H., Wada, T., Bakal, C., Kozieradzki, I., Suzuki, S., Suzuki, N., Nghiem, M., Griffiths, E. K., Krawczyk, C., Bauer, B., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00148-1 · Cited by 336 · cited 2×
“Flag-tagged TBK1 and its catalytically inactive mutant, K38A, were provided by Dr. Chen Wang (Shanghai Institutes for Biological Sciences).”
Novel cross-talk within the IKK family controls innate immunity
Clark, K., Peggie, M., Plater, L., Sorcek, R. J., Young, E. R. R., Madwed, J. B., Hough, J., McIver, E. G., & Cohen, P. (2011) · Biochemical Journal · doi:10.1042/bj20101701 · Cited by 326 · cited 2×
“Moreover, a small molecule inhibitor of TBK1, MRT67307 28 , efficiently inhibited the AKT degradation (Fig.”
Fingolimod for Multiple Sclerosis
Pelletier, D., & Hafler, D. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1101691 · Cited by 315 · cited 1×
“A hallmark of the CNS-migrating autoimmune T cells is the high level expression of the transcription factor KLF2 and its target gene S1PR1, the latter of which has become an attractive target for MS therapy 24,30,31 .”
Groves, A., Kihara, Y., & Chun, J. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.02.011 · Cited by 314
A requirement for CARMA1 in TCR-induced NF-κB activation
Wang, D., You, Y., Case, S. M., McAllister-Lucas, L. M., Wang, L., DiStefano, P. S., Nuñez, G., Bertin, J., & Lin, X. (2002) · Nature Immunology · doi:10.1038/ni824 · Cited by 292
The IκB kinase complex: master regulator of NF-κB signaling
Solt, L. A., & May, M. J. (2008) · Immunologic Research · doi:10.1007/s12026-008-8025-1 · Cited by 284
Reiley, W. W., Jin, W., Lee, A. J., Wright, A., Wu, X., Tewalt, E. F., Leonard, T. O., Norbury, C. C., Fitzpatrick, L., Zhang, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062694 · Cited by 254 · cited 1×
“For protein-phosphorylation analysis and kinase assays, purified T cells were stimulated by a crosslinking method 49 .”
Self-citationConvergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response
Hiscott, J. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.002 · Cited by 239 · cited 3×
“However, unlike the typical IKKs, TBK1 and IKK ε are dispensable for NF-κ B activation but are required for activation of interferon-responsive factor 3 (IRF3), a transcription factor mediating type I IFN gene expression 14 .”
Metabolism, migration and memory in cytotoxic T cells
Finlay, D., & Cantrell, D. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2888 · Cited by 225 · cited 2×
“Antigen-activated T cells are initially retained in draining lymph nodes to undergo differentiation and subsequently exit the lymph nodes and migrate to peripheral site of infection or inflammation 21 .”
IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation
Xie, X., Zhang, D., Zhao, B., Lu, M.-K., You, M., Condorelli, G., Wang, C.-Y., & Guan, K.-L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016132108 · Cited by 223
Sebzda, E., Zou, Z., Lee, J. S., Wang, T., & Kahn, M. L. (2008) · Nature Immunology · doi:10.1038/ni1565 · Cited by 213 · cited 2×
“Besides mTORC1, several other factors in the related pathways, including the transcription factors Foxo1 and KLF2, are required for maintaining T-cell homeostasis 37,38 .”
Fabre, S., Carrette, F., Chen, J., Lang, V., Semichon, M., Denoyelle, C., Lazar, V., Cagnard, N., Dubart-Kupperschmitt, A., Mangeney, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2980 · Cited by 187 · cited 1×
“The transcription factor Foxo1, which is negatively regulated by AKT, has been implicated in the induction of KLF2 and other migration-regulatory genes 38,42,43 .”
T‐cell trafficking in the central nervous system
Sallusto, F., Impellizzieri, D., Basso, C., Laroni, A., Uccelli, A., Lanzavecchia, A., & Engelhardt, B. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01140.x · Cited by 186 · cited 1×
“It is generally believed that in MS and EAE, autoimmune T cells are primed by myelin-specific antigens and then migrate across the blood-brain barrier to enter the CNS, where they become reactivated and mediate inflammation and neuronal damage 4,5 .”
T-cell signalling and autoimmunity: molecular mechanisms of disease
Ohashi, P. S. (2002) · Nature reviews. Immunology · doi:10.1038/nri822 · Cited by 181 · cited 1×
“Autoimmunity occurs as a result of T-cell activation by antigens derived from self-tissues 1 .”
Modeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 174 · cited 3×
“However, unlike the typical IKKs, TBK1 and IKK ε are dispensable for NF-κ B activation but are required for activation of interferon-responsive factor 3 (IRF3), a transcription factor mediating type I IFN gene expression 14 .”
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W. W., Zhang, M., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 163
Self-citationKopp, E. B. (2004) · Medical Entomology and Zoology · Cited by 160
Ionizing radiation activates the ATM kinase throughout the cell cycle
Pandita, T. K., Lieberman, H. B., Lim, D., Dhar, S., Zheng, W., Taya, Y., & Kastan, M. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203444 · Cited by 155
Uhlik, M., Good, L., Xiao, G., Harhaj, E. W., Zandi, E., Karin, M., & Sun, S.-C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21132 · Cited by 154
Self-citationThe kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
Jin, J., Xiao, Y., Chang, J.-H., Yu, J., Hu, H., Starr, R., Brittain, G. C., Chang, M., Cheng, X., & Sun, S.-C. (2012) · Nature Immunology · doi:10.1038/ni.2423 · Cited by 136
Self-citationFabre, S., Lang, V., Harriague, J., Jobart, A., Unterman, T. G., Trautmann, A., & Bismuth, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4161 · Cited by 126 · cited 1×
“The phosphorylation of Foxo1, a known target of AKT 25 , was also higher in the TBK1-deficient T cells (Fig.”
Joung, S. M., Park, Z., Rani, S., Takeuchi, O., Akira, S., & Lee, J. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903534 · Cited by 126 · cited 3×
“Studies using immortalized MEF and cancer cell lines suggest a positive role of TBK1 in the regulation of AKT 29,45 .”
InfluentialSystematic review of genome-wide expression studies in multiple sclerosis
Kemppinen, A., Kaprio, J. A., Palotie, A. V., & Saarela, J. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000053 · Cited by 126 · cited 1×
“Consistently, TBK1 expression was also shown to be elevated (2.41 and 1.79 folds) in two MS PBMC microarray databases 34,35 .”
InfluentialHarhaj, E. W., Good, L., Xiao, G., Uhlik, M. T., Cvijic, M. E., Rivera-Walsh, I., & Sun, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203445 · Cited by 115
Self-citationIκB kinase ɛ (IKKɛ): A therapeutic target in inflammation and cancer
Verhelst, K., Verstrepen, L., Carpentier, I., & Beyaert, R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.007 · Cited by 110
Sporici, R., & Issekutz, T. B. (2010) · European Journal of Immunology · doi:10.1002/eji.200939975 · Cited by 86
Phosphoinositide 3‐kinase and the mammalian target of rapamycin pathways control T cell migration
Finlay, D., & Cantrell, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05134.x · Cited by 83
Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis
Zhang, F., Shi, Y., Wang, L., & Sriram, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016795 · Cited by 59 · cited 1×
“Consistently, TBK1 expression was also shown to be elevated (2.41 and 1.79 folds) in two MS PBMC microarray databases 34,35 .”
InfluentialRougerie, P., Largeteau, Q., Megrelis, L., Carrette, F., Lejeune, T., Toffali, L., Rossi, B., Zeghouf, M., Cherfils, J., Constantin, G., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201174 · Cited by 47 · cited 1×
“The transcription factor Foxo1, which is negatively regulated by AKT, has been implicated in the induction of KLF2 and other migration-regulatory genes 38,42,43 .”
Naïve T Cells Re-Distribute to the Lungs of Selectin Ligand Deficient Mice
Harp, J. R., & Onami, T. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010973 · Cited by 20 · cited 1×
“2d), they did not have a defect in T-cell homing to the lymph nodes as shown for the CD62L-deficient mice 19,20 .”
Study of T-cell signaling by somatic cell mutagenesis and complementation cloning
Cvijic, M. E., Xiao, G., & Sun, S. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00191-1 · Cited by 13
Self-citation
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Jenkins, R. W., Aref, A. R., Lizotte, P. H., Ivanova, E., Stinson, S., Zhou, C. W., Bowden, M., Deng, J., Liu, H., Miao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0833 · Cited by 594
“To determine if MDOTS profiling predicted in vivo response to dual TBK1/IKKε inhibition, BALB/c mice bearing CT26 tumors were treated with Cmpd 1 ± anti–PD-L1 (Fig.”
BackgroundInfluentialKinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Oduro, P. K., Zheng, X., Wei, J., Yang, Y., Wang, Y., Zhang, H., Liu, E., Gao, X., Du, M., & Wang, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.011 · Cited by 339
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
“Interestingly, when challenged with the EAE model, ablating TBK1 in T cells led to retention of effector T cells in the draining lymph nodes, resulting in decreased numbers of T cells infiltrating into the brain, and a less severe disease phenotype [165].”
Background
Metadata
- Authors
- Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., Zal, T., & Sun, S.-C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Fukui (JP)
- Corresponding author
- Sun, Shao-Cong
- ORCID
- Venue
- Nature Communications
- Published
- 2015-01-21
- Volume
- 6
- Issue
- 1
- Pages
- 6074-6074
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4302769
- OpenAlex
- W1963961512
- Cited by
- 118
- References
- 53
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 18 · 2023: 8 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 12 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 2
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (AI064639)
- University of Texas MD Anderson Cancer Center (P30-CA-016672, AI057555, AI104519)
- National Cancer Institute (R01CA181184, P30CA016672)
- National Institute of General Medical Sciences (GM84459, R01GM084459)
- National Institute of Allergy and Infectious Diseases (AI064639, R01AI057555, R37AI064639, R01AI064639, R01AI104519, AI104519, AI057555)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- TBK1, T cell activation, T cell migration, neuroinflammation, experimental autoimmune encephalomyelitis, Akt, mTORC1, draining lymph nodes, TBK1 inhibitors, autoimmunity
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Cell Movement, Cell Separation, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Gene Expression Regulation, Humans, Lymphocyte Activation, Macrophages, Male, Mice, Inbred C57BL, Orthomyxoviridae, Phenotype, Phosphorylation, T-Lymphocytes, Signal Transduction, CD4-Positive T-Lymphocytes, Autoimmunity, Protein Serine-Threonine Kinases, Mice, Knockout, CD8-Positive T-Lymphocytes, Jurkat Cells, Multiprotein Complexes, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.